FluoGuide A/S is a clinical stage biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Meet the team

FluoGuide has a strong management team with expertise across all areas needed to keep FluoGuide moving forward swiftly, from discovering imaging techniques and developing new healthcare products, to international commercialization of medical solutions.


See all members of FluoGuide’s management here.

For unsolicited job applications, please, write to: career@fluoguide.com